These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 34413105)

  • 21. Outpatient Interventions for Managing Acute Complications of Chronic Diseases: A Scoping Review and Implications for Patients With CKD.
    Elliott MJ; Love S; Donald M; Manns B; Donald T; Premji Z; Hemmelgarn BR; Grinman M; Lang E; Ronksley PE
    Am J Kidney Dis; 2020 Dec; 76(6):794-805. PubMed ID: 32479925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. End-of-life care for people with chronic kidney disease: cause of death, place of death and hospital costs.
    Kerr M; Matthews B; Medcalf JF; O'Donoghue D
    Nephrol Dial Transplant; 2017 Sep; 32(9):1504-1509. PubMed ID: 27207901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Socioecologic factors as predictors of readiness for self-management and transition, medication adherence, and health care utilization among adolescents and young adults with chronic kidney disease.
    Javalkar K; Fenton N; Cohen S; Ferris M
    Prev Chronic Dis; 2014 Jul; 11():E117. PubMed ID: 25010999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyperuricaemia, gout and allopurinol in the CKD Queensland registry.
    Jeyaruban A; Hoy W; Cameron A; Healy H; Wang Z; Zhang J; Mallett A
    J Nephrol; 2021 Jun; 34(3):753-762. PubMed ID: 33439469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comorbidity as a driver of adverse outcomes in people with chronic kidney disease.
    Tonelli M; Wiebe N; Guthrie B; James MT; Quan H; Fortin M; Klarenbach SW; Sargious P; Straus S; Lewanczuk R; Ronksley PE; Manns BJ; Hemmelgarn BR
    Kidney Int; 2015 Oct; 88(4):859-66. PubMed ID: 26221754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost implication of inpatient care of chronic kidney disease patients in a tertiary hospital in Southwest Nigeria.
    Adejumo OA; Akinbodewa AA; Ogunleye A; Enikuomehin AC; Lawal OM
    Saudi J Kidney Dis Transpl; 2020; 31(1):209-214. PubMed ID: 32129215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The association of acute kidney injury in the critically ill and postdischarge outcomes: a cohort study*.
    Horkan CM; Purtle SW; Mendu ML; Moromizato T; Gibbons FK; Christopher KB
    Crit Care Med; 2015 Feb; 43(2):354-64. PubMed ID: 25474534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute Care QUAliTy in chronic Kidney disease (ACQUATIK): a prospective cohort study exploring outcomes of patients with chronic kidney disease.
    Arnold JJ; Hayer M; Sharif A; Begaj I; Tabriez M; Bagnall D; Ray D; Hoye C; Nazir M; Dutton M; Fifer L; Kirkham K; Sims D; Townend JN; Gill PS; Dasgupta I; Cockwell P; Ferro CJ
    BMJ Open; 2015 May; 5(4):e006987. PubMed ID: 25941178
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incident Chronic Kidney Disease After Radical Nephrectomy for Renal Cell Carcinoma.
    Ellis RJ; White VM; Bolton DM; Coory MD; Davis ID; Francis RS; Giles GG; Gobe GC; Marco DJT; Neale RE; Wood ST; Jordan SJ;
    Clin Genitourin Cancer; 2019 Jun; 17(3):e581-e591. PubMed ID: 30975606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gout and the risk of advanced chronic kidney disease in the UK health system: a national cohort study.
    Stack AG; Johnson ME; Blak B; Klein A; Carpenter L; Morlock R; Maguire AR; Parsons VL
    BMJ Open; 2019 Aug; 9(8):e031550. PubMed ID: 31462487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prevalence of chronic kidney disease and associated factors among patients admitted at princess marina hospital, Gaborone, Botswana.
    Rwegerera GM; Bayani M; Taolo EK; Habte D
    Niger J Clin Pract; 2017 Mar; 20(3):313-319. PubMed ID: 28256486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systematic reviews of the effectiveness of day care for people with severe mental disorders: (1) acute day hospital versus admission; (2) vocational rehabilitation; (3) day hospital versus outpatient care.
    Marshall M; Crowther R; Almaraz-Serrano A; Creed F; Sledge W; Kluiter H; Roberts C; Hill E; Wiersma D; Bond GR; Huxley P; Tyrer P
    Health Technol Assess; 2001; 5(21):1-75. PubMed ID: 11532238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Healthcare costs in chronic kidney disease and renal replacement therapy: a population-based cohort study in Sweden.
    Eriksson JK; Neovius M; Jacobson SH; Elinder CG; Hylander B
    BMJ Open; 2016 Oct; 6(10):e012062. PubMed ID: 27855091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of erythropoiesis-stimulating agents on healthcare utilization, costs, and outcomes in chronic kidney disease.
    Maddux FW; Shetty S; del Aguila MA; Nelson MA; Murray BM
    Ann Pharmacother; 2007 Nov; 41(11):1761-9. PubMed ID: 17895328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Economic impact of kidney patients with sepsis in hospital setting].
    Battaglia Y; Guerzoni F; Gigante M; Veronesi M; Oppi C; Forini E; Ullo I; Vagnoni E; Storari A
    G Ital Nefrol; 2019 Dec; 36(6):. PubMed ID: 31830394
    [No Abstract]   [Full Text] [Related]  

  • 36. The prevalence of Fabry disease in a statewide chronic kidney disease cohort - Outcomes of the aCQuiRE (Ckd.Qld fabRy Epidemiology) study.
    Mallett A; Kearey PJ; Cameron A; Healy HG; Denaro C; Thomas M; Lee VW; Stark SL; Fuller M; Wang Z; Hoy WE
    BMC Nephrol; 2022 May; 23(1):169. PubMed ID: 35505287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CKD and the risk of acute, community-acquired infections among older people with diabetes mellitus: a retrospective cohort study using electronic health records.
    McDonald HI; Thomas SL; Millett ER; Nitsch D
    Am J Kidney Dis; 2015 Jul; 66(1):60-8. PubMed ID: 25641062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of chronic kidney disease on mortality and cardiovascular outcomes after acute coronary syndrome: A nationwide data linkage study (ANZACS-QI 44).
    Pilmore HL; Xiong F; Choi Y; Poppe K; Lee M; Legget M; Kerr A
    Nephrology (Carlton); 2020 Jul; 25(7):535-543. PubMed ID: 32105376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association Between β-Blocker Use and Mortality/Morbidity in Patients With Heart Failure With Reduced, Midrange, and Preserved Ejection Fraction and Advanced Chronic Kidney Disease.
    Fu EL; Uijl A; Dekker FW; Lund LH; Savarese G; Carrero JJ
    Circ Heart Fail; 2020 Nov; 13(11):e007180. PubMed ID: 33070637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Senior high-cost healthcare users' resource utilization and outcomes: a protocol of a retrospective matched cohort study in Canada.
    Muratov S; Lee J; Holbrook A; Paterson JM; Guertin JR; Mbuagbaw L; Gomes T; Khuu W; Pequeno P; Costa AP; Tarride JE
    BMJ Open; 2017 Dec; 7(12):e018488. PubMed ID: 29282266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.